Gaining: Pediatric patients and use of atypical antipsychotics

American Journal of Psychiatry

Volumn 163, Issue 12, 2006, Pages 2034-2036

  Towbin, Kenneth E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; METFORMIN;

ACUTE KIDNEY FAILURE; ATTENTION DISTURBANCE; AUTISM; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CYANOCOBALAMIN DEFICIENCY; DRUG SAFETY; DRUG USE; EDITORIAL; FOLIC ACID DEFICIENCY; HUMAN; INSULIN SENSITIVITY; LACTIC ACIDOSIS; LIVER DISEASE; MEDICAID; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OPPOSITIONAL DEFIANT DISORDER; ORAL GLUCOSE TOLERANCE TEST; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION; WAIST CIRCUMFERENCE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 33846332023     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2006.163.12.2034     Document Type: Editorial

References (13)

1. Baptista T, Martinez J, Lacruz A, Rangel N, Beaulieu S, Serrano A, Arape Y, Martinez M, de Mendoza S, Teneud L, Hernandez L: Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial. Can J Psychiatry 2006; 51:192-196
2. Morrison JA, Cottingham EM, Barton BA: Metformin for weight loss in pediatric patients taking psychotropic drugs. Am J Psychiatry 2002; 159:655-657
3. Patel NC, Crismon ML, Hoagwood K, Johnsrud MT, Rascati KL, Wilson JP, Jensen PS: Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry 2005; 44: 548-556
4. Olfson M, Blanco C, Liu L, Moreno C, Laje G: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006; 63:679-685
5. Fedorowicz VJ, Fombonne E: Metabolic side effects of atypical antipsychotics in children: a literature review. J Psychopharmacol 2005; 19:533-550
6. Safer DJ: A comparison of risperidone-induced weight gain across the age span. J Clin Psychopharmacol 2004; 24:429-436
7. Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop JC , Borger van der Burg B, Donker AJ, Stehouwer CD: Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 2003; 254:455-463
8. Holstein A, Stumvoll M: Contraindications can damage your health - is metformin a case in point? Diabetologia 2005; 48:2454-2459
9. Chan NN, Fauvel NJ, Feher MD: Non-steroidal anti-inflammatory drugs and metformin: a cause for concern? (letter). Lancet 1998; 352:201
10. Centorrino F, Wurtman JJ, Duca KA, Fellman VH, Fogarty KV, Berry JM, Guay DM, Romeling M, Kidwell J, Cincotta SL, Baldessarini RJ: Weight loss in overweight patients maintained on atypical antipsychotic agents. Int J Obes 2006; 30:1011-1016
11. Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M: Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry 2004; 65:471-477
12. Cheng-Shannon J, McGough JJ, Pataki C, McCracken JT: Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 2004; 14:372-394
13. Patel NC, Crismon ML, Hoagwood K, Jensen PS: Unanswered questions regarding atypical antipsychotic use in aggressive children and adolescents. J Child Adolesc Psychopharmacol 2005; 15:270-284